< Back to previous page
Researcher
Ema Romao
- Keywords:Applied biological sciences, biotechnology
- Disciplines:Other biological sciences not elsewhere classified
Affiliations
- Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From14 Aug 2015 → Today - Department of Bio-engineering Sciences (Department)
Member
From12 Mar 2025 → Today - Department of Bio-engineering Sciences (Department)
Member
From12 Mar 2025 → 29 Apr 2025 - Department of Bio-engineering Sciences (Department)
Member
From1 Apr 2024 → Today - Brussels Center for Immunology (Research group)
Member
From1 Apr 2024 → Today - FORMER_Cellular and Molecular Immunology (Research group)
Member
From1 May 2020 → 20 Oct 2022 - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From20 Jul 2016 → 7 Sep 2017 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2013 → 31 Mar 2019 - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From23 Sep 2011 → 13 Sep 2013
Projects
1 - 1 of 1
- Development of Therapeutic Nanobodies Targeting Human Acute Myeloid Leukemia Stem Cells.From1 Oct 2013 → 30 Sep 2017Funding: FWO fellowships
Publications
1 - 10 of 19
- Evidence for a model of conformational change by the Plasmodium falciparum circumsporozoite protein during sporozoite development in the mosquito host through the use of camelid single-domain antibodies.(2025)Published in: Infect. Immun.ISSN: 0019-9567Issue: 6Volume: 93
- Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids(2024)Published in: NATURE COMMUNICATIONSISSN: 2041-1723Issue: 1Volume: 15Pages: 1779
- Nanobodies as binding-chaperones stabilize the recombinant Bombyx mori acetylcholinesterase and protect the enzyme activity in pesticide detection(2022)Published in: Enzyme and Microbial TechnologyISSN: 0141-0229Volume: 155
- Development of Nanobodies against Mal de Río Cuarto virus major viroplasm protein P9-1 for diagnostic sandwich ELISA and immunodetection(2021)Published in: Sci. Rep.ISSN: 2045-2322Issue: 1Volume: 11
- Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha(2021)Published in: Frontiers In ImmunologyISSN: 1664-3224Volume: 12
- Agonistic nanobodies and antibodies to human VISTA(2021)Published in: Monoclonal antibodiesISSN: 1942-0862Issue: 1Volume: 13
- Intrabody Targeting HIF-1α Mediates Transcriptional Downregulation of Target Genes Related to Solid Tumors(2021)Published in: Int. J. Mol. Sci.ISSN: 1661-6596Issue: 22Volume: 22
- Development of Nanobodies Against Hemorrhagic and Myotoxic Components of Bothrops atrox Snake Venom(2020)Published in: Frontiers In ImmunologyISSN: 1664-3224Volume: 11
- Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33(2020)Published in: Int. J. Mol. Sci.ISSN: 1661-6596Issue: 1Volume: 21
- Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment(2019)Published in: Int. J. Mol. Sci.ISSN: 1661-6596Issue: 19Volume: 20